Burke MT - Search Results

1

Phase II trial of trimetrexate in patients with stage III and IV non-small-cell lung cancer.

Kris MG, D'Acquisto RW, Gralla RJ, Burke MT, Marks LD, Fanucchi MP, Heelan RT. Kris MG, et al. Among authors: burke mt. Am J Clin Oncol. 1989 Feb;12(1):24-6. doi: 10.1097/00000421-198902000-00006. Am J Clin Oncol. 1989. PMID: 2536213

2

Phase II study of 10-ethyl-10-deaza-aminopterin in patients with stage III and IV non-small-cell lung cancer.

Shum KY, Kris MG, Gralla RJ, Burke MT, Marks LD, Heelan RT. Shum KY, et al. Among authors: burke mt. J Clin Oncol. 1988 Mar;6(3):446-50. doi: 10.1200/JCO.1988.6.3.446. J Clin Oncol. 1988. PMID: 2832548

3

Phase II trial of oral 4-demethoxydaunorubicin in patients with non-small cell lung cancer.

Kris MG, Gralla RJ, Kelsen DP, Casper ES, Burke MT, Fiore JJ, Cibas IR, Heelan RT. Kris MG, et al. Among authors: burke mt. Am J Clin Oncol. 1985 Oct;8(5):377-9. doi: 10.1097/00000421-198510000-00007. Am J Clin Oncol. 1985. PMID: 3864366

4

Preoperative and adjuvant chemotherapy in locally advanced non-small cell lung cancer.

Kris MG, Gralla RJ, Martini N, Stampleman LV, Burke MT. Kris MG, et al. Among authors: burke mt. Surg Clin North Am. 1987 Oct;67(5):1051-9. doi: 10.1016/s0039-6109(16)44342-2. Surg Clin North Am. 1987. PMID: 2820069 Clinical Trial.

5

Trial of vindesine plus mitomycin in stage-3 non-small cell lung cancer. An active regimen for outpatient treatment.

Kris MG, Gralla RJ, Kelsen DP, Casper ES, Burke MT, Fiore JJ, Cibas IR, Heelan RT. Kris MG, et al. Among authors: burke mt. Chest. 1985 Mar;87(3):368-72. doi: 10.1378/chest.87.3.368. Chest. 1985. PMID: 2982552 Clinical Trial.

6

Phase II trial of oral piritrexim (BW301U) in patients with stage III non-small cell lung cancer.

Kris MG, Gralla RJ, Burke MT, Berkowitz LD, Marks LD, Kelsen DP, Heelan RT. Kris MG, et al. Among authors: burke mt. Cancer Treat Rep. 1987 Jul-Aug;71(7-8):763-4. Cancer Treat Rep. 1987. PMID: 3038318 No abstract available.

7

Phase II trial of esorubicin in patients with advanced non-small cell lung cancer.

Kris MG, Gralla RJ, Burke MT, Fiore JJ, Kelsen DP, Marks LD, Heelan RT. Kris MG, et al. Among authors: burke mt. Cancer Treat Rep. 1987 Jul-Aug;71(7-8):783-4. Cancer Treat Rep. 1987. PMID: 3038319 No abstract available.

8

Trial of the combination of mitomycin, vindesine, and cisplatin in patients with advanced non-small cell lung cancer.

Kris MG, Gralla RJ, Wertheim MS, Kelsen DP, O'Connell JP, Burke MT, Fiore JJ, Cibas IR, Heelan RT. Kris MG, et al. Among authors: burke mt. Cancer Treat Rep. 1986 Sep;70(9):1091-6. Cancer Treat Rep. 1986. PMID: 3527408 Clinical Trial.

9

Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment.

Kris MG, Gralla RJ, Kalman LA, Kelsen DP, Casper ES, Burke MT, Groshen S, Cibas IR, Bagin R, Heelan RT. Kris MG, et al. Among authors: burke mt. Cancer Treat Rep. 1985 Apr;69(4):387-95. Cancer Treat Rep. 1985. PMID: 3888388 Clinical Trial.

10

Dyspnea following vinblastine or vindesine administration in patients receiving mitomycin plus vinca alkaloid combination therapy.

Kris MG, Pablo D, Gralla RJ, Burke MT, Prestifilippo J, Lewin D. Kris MG, et al. Among authors: burke mt. Cancer Treat Rep. 1984 Jul-Aug;68(7-8):1029-31. Cancer Treat Rep. 1984. PMID: 6744336

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters